Riskpilot← Back to searchSign inGet full accessDAHLE MEDICAL AS
ASActiveOrg 912414256Rosenlundvegen 4, 2619 LillehammerWholesale of pharmaceutical and medical goods · NACE 4646Est. 201323 employees
Revenue 2024
NOK 114,8M
+5% vs 2023
EBITDA margin
2.2%
+63% vs 2023
Equity ratio
45.9%
Financial strength
Net profit 2024
NOK 1,5M
+99% vs 2023
| Revenue | NOK 114,8M | +5% |
| EBITDA | NOK 2,6M | +63% |
| Net profit | NOK 1,5M | +99% |
| Total assets | NOK 44,1M | -2% |
| Equity | NOK 20,2M | -23% |
| Employees | 23 | — |
Legal name
DAHLE MEDICAL AS
Org number
912414256
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. september 2013
Share capital
NOK 2 100 000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Varehandel, samt det som naturlig står i forbindelse med dette.
Address
Rosenlundvegen 4, 2619 Lillehammer
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 124 221 | 121 558 | 103 808 | 109 618 | 114 782 |
| Staff expenses | −16 019 | −17 201 | −17 960 | −20 516 | −21 498 |
| EBITDA | 24 602 | 21 501 | 6 019 | 1 570 | 2 560 |
| Depreciation & amort. | −362 | −435 | −456 | −584 | −656 |
| EBIT | 24 240 | 21 066 | 5 564 | 986 | 1 903 |
| Net financials | 35 | 98 | 31 | 5 | 77 |
| Profit before tax | 24 276 | 21 165 | 5 594 | 991 | 1 980 |
| Tax | 5 343 | 4 657 | 1 231 | 217 | 437 |
| Net profit | 18 933 | 16 507 | 4 363 | 773 | 1 543 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 59 257 | 59 737 | 44 484 | 45 117 | 44 057 |
| Equity | 22 012 | 25 259 | 26 112 | 26 262 | 20 224 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 37 245 | 34 477 | 18 372 | 18 855 | 23 833 |
| Total debt | 37 245 | 34 477 | 18 372 | 18 855 | 23 833 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20202024
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20202024
Net profit margin
1.3%
This company
8.1%
Market median
-84% vs market
20202024
Asset turnover
2.61×
This company
1.12×
Market median
+133% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EI Chief Executive Officer | Chief Executive Officer | 2013 |
ET Deputy Member | Deputy Member | 2013 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dahle Medical Holding As
DAHLE MEDICAL AS Board members of DAHLE MEDICAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ernst Ingvald Dahle | Chief Executive Officer | 0 companies |
| Elin Tranulis | Deputy Member | 0 companies |